Automate Your Wheel Strategy on HUM
With Tiblio's Option Bot, you can configure your own wheel strategy including HUM - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol HUM
- Rev/Share 1021.3292
- Book/Share 151.7766
- PB 1.7199
- Debt/Equity 0.6902
- CurrentRatio 0.0
- ROIC 0.1014
- MktCap 31291145426.0
- FreeCF/Share 20.2341
- PFCF 12.8295
- PE 19.8989
- Debt/Assets 0.2499
- DivYield 0.0136
- ROE 0.0902
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 5
- P/B Score 3
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | HUM | Evercore ISI | -- | In-line | -- | $295 | Sept. 22, 2025 |
| Upgrade | HUM | Raymond James | Market Perform | Outperform | -- | $315 | May 1, 2025 |
| Initiation | HUM | KeyBanc Capital Markets | -- | Sector Weight | -- | -- | Oct. 11, 2024 |
| Upgrade | HUM | Bernstein | Market Perform | Outperform | -- | $308 | Oct. 8, 2024 |
| Downgrade | HUM | TD Cowen | Buy | Hold | $402 | $261 | Oct. 7, 2024 |
| Downgrade | HUM | Jefferies | Buy | Hold | $519 | $253 | Oct. 7, 2024 |
| Downgrade | HUM | Piper Sandler | Overweight | Neutral | $392 | $274 | Oct. 3, 2024 |
| Downgrade | HUM | Leerink Partners | Outperform | Market Perform | $400 | $250 | Oct. 2, 2024 |
| Downgrade | HUM | Stephens | Overweight | Equal Weight | $400 | $250 | Oct. 2, 2024 |
| Downgrade | HUM | BofA Securities | Neutral | Underperform | $376 | $247 | Oct. 2, 2024 |
News
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Humana Inc. (HUM) and Encourages Investors to Learn More About the Investigation
Published: May 08, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / May 8, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Humana Inc. ("Humana" or "the Company") (NYSE:HUM). Investors who purchased Humana securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/HUM.
Read More
HUM ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Humana Inc. Shareholders Who Lost Money
Published: May 08, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / May 8, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Humana Inc. ("Humana Inc.") (NYSE:HUM) concerning possible violations of federal securities laws. On May 1, 2025, the U.S. Department of Justice announced it had filed a False Claims Act complaint against several health insurance companies and insurance broker organizations, including Humana.
Read More
Levi & Korsinsky Reminds Shareholders of an Investigation into Humana Inc. (HUM) Regarding Potential Securities Fraud Allegations
Published: May 07, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / May 7, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Humana Inc. ("Humana Inc.") (NYSE:HUM) concerning possible violations of federal securities laws. On May 1, 2025, the U.S. Department of Justice announced it had filed a False Claims Act complaint against several health insurance companies and insurance broker organizations, including Humana.
Read More
Bronstein, Gewirtz & Grossman, LLC Is Investigating Humana Inc. (HUM) And Encourages Stockholders to Connect
Published: May 07, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / May 7, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Humana Inc. ("Humana" or "the Company") (NYSE:HUM). Investors who purchased Humana securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/HUM.
Read More
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Humana Inc. (HUM)
Published: May 07, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / May 7, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Humana Inc. ("Humana Inc.") (NYSE:HUM) concerning possible violations of federal securities laws. On May 1, 2025, the U.S. Department of Justice announced it had filed a False Claims Act complaint against several health insurance companies and insurance broker organizations, including Humana.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Humana Inc. - HUM
Published: May 07, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / May 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. ("Humana" or the "Company") (NYSE:HUM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Read More
Levi & Korsinsky Reminds Shareholders of an Investigation into Humana Inc. (HUM) Regarding Potential Securities Fraud Allegations
Published: May 06, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / May 6, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Humana Inc. ("Humana Inc.") (NYSE:HUM) concerning possible violations of federal securities laws. On May 1, 2025, the U.S. Department of Justice announced it had filed a False Claims Act complaint against several health insurance companies and insurance broker organizations, including Humana.
Read More
Kirby McInerney LLP Announces Investigation of Claims Against Humana Inc. (HUM) on Behalf of Investors
Published: May 06, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Humana Inc. (“Humana” or the “Company”) (NYSE:HUM). The investigation concerns whether Humana and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
Read More
Humana Inc. Being Investigated on Behalf of Humana Inc. Investors. Contact Levi & Korsinsky For Details.
Published: May 06, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / May 6, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Humana Inc. ("Humana Inc.") (NYSE:HUM) concerning possible violations of federal securities laws. On May 1, 2025, the U.S. Department of Justice announced it had filed a False Claims Act complaint against several health insurance companies and insurance broker organizations, including Humana.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Humana Inc. - HUM
Published: May 06, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , May 6, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. ("Humana" or the "Company") (NYSE: HUM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Read More
An Investigation Has Commenced on Behalf of Humana Inc. Shareholders. Contact Levi & Korsinsky to Discuss your HUM Losses
Published: May 06, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / May 6, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Humana Inc. ("Humana Inc.") (NYSE:HUM) concerning possible violations of federal securities laws. On May 1, 2025, the U.S. Department of Justice announced it had filed a False Claims Act complaint against several health insurance companies and insurance broker organizations, including Humana.
Read More
HUM ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Humana Inc.
Published: May 05, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / May 5, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Humana Inc. ("Humana Inc.") (NYSE:HUM) concerning possible violations of federal securities laws. On May 1, 2025, the U.S. Department of Justice announced it had filed a False Claims Act complaint against several health insurance companies and insurance broker organizations, including Humana.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Humana Inc. – HUM
Published: May 05, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. (“Humana” or the “Company”) (NYSE: HUM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Read More
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Humana Inc. (HUM) and Encourages Stockholders to Learn More About the Investigation
Published: May 05, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / May 5, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Humana Inc. ("Humana" or "the Company") (NYSE:HUM). Investors who purchased Humana securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/HUM.
Read More
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Humana Inc. (HUM) And Encourages Investors to Reach Out
Published: May 02, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / May 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Humana Inc. ("Humana" or "the Company") (NYSE:HUM). Investors who purchased Humana securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/HUM.
Read More
Humana's Q1 Earnings Beat Estimates on CenterWell Segment Strength
Published: April 30, 2025 by: Zacks Investment Research
Sentiment: Positive
HUM's first-quarter results reflect higher primary care revenues and a well-performing Medicare stand-alone PDP business, partly offset by elevated operating costs.
Read More
CNC vs. HUM: Which Stock Is the Better Value Option?
Published: April 30, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors interested in stocks from the Medical - HMOs sector have probably already heard of Centene (CNC) and Humana (HUM). But which of these two stocks presents investors with the better value opportunity right now?
Read More
Humana Cost Cuts, Medicare Advantage Moves Boost Results
Published: April 30, 2025 by: Investopedia
Sentiment: Positive
Humana (HUM) shares edged higher when the health insurer reported better-than-expected results as it lowered costs and pulled out of certain Medicare Advantage plans.
Read More
Humana (HUM) Reports Q1 Earnings: What Key Metrics Have to Say
Published: April 30, 2025 by: Zacks Investment Research
Sentiment: Neutral
While the top- and bottom-line numbers for Humana (HUM) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Read More
Humana, Inc. (HUM) Q1 2025 Earnings Call Transcript
Published: April 30, 2025 by: Seeking Alpha
Sentiment: Neutral
Humana, Inc. (NYSE:HUM ) Q1 2025 - Earnings Conference Call April 30, 2025 8:00 AM ET Company Participants Lisa Stoner - VP, IR James Rechtin - President, CEO & Director Celeste Mellet - CFO George Renaudin - President, Insurance Conference Call Participants Sarah James - Cantor Fitzgerald Ben Hendrix - RBC Capital Markets Justin Lake - Wolfe Research Andrew Mok - Barclays Stephen Baxter - Wells Fargo AJ Rice - UBS Joshua Raskin - Nephron Research Joanna Gajuk - Bank of America Lance Wilkes - Bernstein Erin Wright - Morgan Stanley Lisa Gill - JPMorgan Michael Hall - Baird David …
Read More
Humana's exit of some ‘unprofitable' Medicare plans helps fuel a big profit beat
Published: April 30, 2025 by: Market Watch
Sentiment: Positive
While Humana affirmed its full-year profit outlook, which can be viewed as a positive in the current uncertain economic environment, quarterly revenue came up a bit shy, and the earnings outlook for the current quarter was below Wall Street projections.
Read More
Humana (HUM) Q1 Earnings Surpass Estimates
Published: April 30, 2025 by: Zacks Investment Research
Sentiment: Positive
Humana (HUM) came out with quarterly earnings of $11.58 per share, beating the Zacks Consensus Estimate of $9.98 per share. This compares to earnings of $7.23 per share a year ago.
Read More
Humana beats first-quarter profit estimates on lower costs
Published: April 30, 2025 by: Reuters
Sentiment: Positive
Humana beat Wall Street estimates for first-quarter profit on Wednesday, as the health insurer spent less on medical services than expected.
Read More
Humana Reports First Quarter 2025 Financial Results; Affirms Full Year 2025 Adjusted Financial Guidance
Published: April 30, 2025 by: Business Wire
Sentiment: Neutral
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today reported consolidated pretax results and net earnings per share (EPS) for the quarter ended March 31, 2025 (1Q25) versus the quarter ended March 31, 2024 (1Q24) as noted in the tables below. Consolidated income before income taxes and equity in net losses (pretax results) in millions 1Q25 (a) 1Q24 (a) Generally Accepted Accounting Principles (GAAP) $1,691 $1,014 Amortization associated with identifiable intangibles 15 16 Put/call v.
Read More
Can Humana Beat Q1 Earnings Estimates on Growing Premiums?
Published: April 28, 2025 by: Zacks Investment Research
Sentiment: Positive
HUM's first-quarter results are likely to benefit from higher Medicare stand-alone PDP revenues.
Read More
New Report from the Humana Foundation Examines Best-Practices in Community-Engaged Research
Published: April 16, 2025 by: Business Wire
Sentiment: Neutral
LOUISVILLE, Ky.--(BUSINESS WIRE)--The Humana Foundation, the philanthropic arm of Humana Inc. for the past 44 years, today announced the publication of its new report, Strengthening Science and Community Impact Through Equitable Research Practices. The report examines innovative research methods adopted by the Foundation's partners to promote health equity in public health research through community-engaged research practices. “Our report offers pivotal insights and recommendations to help fund.
Read More
UnitedHealth vs. Humana: Which Healthcare Stock Should You Buy Now?
Published: April 09, 2025 by: Zacks Investment Research
Sentiment: Positive
The CMS announced a hike in MA payments for fiscal year 2026, which will likely deliver a notable boost to UNH & HUM's bottom lines.
Read More
Humana (HUM) Surges 10.7%: Is This an Indication of Further Gains?
Published: April 09, 2025 by: Zacks Investment Research
Sentiment: Positive
Humana (HUM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Read More
Measuring WBA Merger, HUM "Bonds Play," CVS & UNH Options Trades
Published: April 08, 2025 by: Schwab Network
Sentiment: Positive
Spencer Hakimian believes the healthcare sector will withstand the tariff storm well compared to other industries. On specific stocks, he doesn't expect much movement from Walgreens (WBA) after its top line earnings beat, but he expects the planned merger to shake market movement.
Read More
US Health Insurance Stocks Rally After $25 Billion Federal Boost To Medicare Payments
Published: April 08, 2025 by: Forbes
Sentiment: Positive
Health insurance stocks soared Tuesday morning on the first full day of trading after the U.S. government announced a more than 5% average increase in government reimbursement rates for 2026 Medicare Advantage plans run by private insurers.
Read More
About Humana Inc. (HUM)
- IPO Date 1981-12-31
- Website https://www.humana.com
- Industry Medical - Healthcare Plans
- CEO James A. Rechtin
- Employees 65680